Origami Therapeutics, Inc. YC 지원서

Winter 2022Active

Origami Therapeutics, Inc.은(는) Winter 2022 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Winter 2022
산업: HealthcareTherapeutics
팀 규모: 4
상태: Active
출시됨: 2022

창업자

Beth HoffmanFounder

Origami Therapeutics, Inc.의 사업 내용

Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified small molecules that reduce the toxic mutated protein, suppress mutant protein-induced toxicities in human disease neurons and get into the brain. We anticipate that this approach will be broadly applicable to traditionally “undruggable” targets in other neurological diseases.

Origami Therapeutics, Inc.의 YC 지원서, 재구성됨

Y Combinator 지원

Origami Therapeutics, Inc., Winter 2022 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Origami Therapeutics, Inc.

Describe what your company does in 50 characters or less.

Oral drugs to halt neurodegeneration

What is your company going to make? Please describe your product and what it does or will do.

We develop oral small molecule protein degraders aimed at halting neurodegeneration by removing toxic proteins that cause diseases like Huntington's. We use proprietary human disease models to select molecules that get into the brain and reduce mutant proteins in neurons.

Where do you live now, and where would the company be based after YC?

We live in San Diego, CA and will be based here after YC.

Explain your decision regarding location.

San Diego's biotech ecosystem and access to scientific talent fit our development timeline and goals.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Origami Therapeutics, Inc.의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Origami Therapeutics, Inc.의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Origami Therapeutics, Inc.과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.